Of note, observational and genetic evidence has supported an association of low CRP levels with increased risk of Alzheimer’s disease [29], and further work is required to delineate the dose–response relationship between IL-6 signaling mediated changes in CRP levels and potential adverse outcomes. The gene discussed is IL6; the disease is Alzheimer disease.